Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Jacob Aptekar"'
3
Predictors of severe CRS in longitudinal CAR T-cell clinical trial data
Autor: Caleb Strait, Jacob Aptekar, Michael W. Kattan, Vibhu Agarwal
Publikováno v: Journal of Clinical Oncology. 40:2540-2540
2540 Background: Cytokine release syndrome (CRS) is a life-threatening toxicity of chimeric antigen receptor (CAR) T-cell therapy and there is a limited understanding of its risk factors. Known markers of severe CRS lack specificity or require centra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b2efa6c3148e2fbc65217a86323a5797
https://doi.org/10.1200/jco.2022.40.16_suppl.2540
Zobrazit plný text záznamu
4
Patterns of Hematologic Function and Cytokine Release Syndrome Severity in ALL Patients Receiving CAR-T and TCR-T Therapies Using Pooled Clinical Trial Data
Autor: Emelly Rusli, Aniketh Talwai, Vibhu Agarwal, Jacob Aptekar, Yahav Itzkovich, Aaron Galaznik, Robert Buderi, Lilia Bouzit, Alexandru Socolov
Publikováno v: Blood. 138:4826-4826
Background: Despite the potential for durable disease remission seen with Chimeric Antigen Receptor (CAR-T) and T-Cell Receptor (TCR-T) therapies, their use is limited by the potential for acute toxicity from Cytokine-Release Syndrome (CRS).Across al
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2fe7cba904c1291e3cb5fb1679d6ddb8
https://doi.org/10.1182/blood-2021-149180
Zobrazit plný text záznamu
5
Elektronická kniha
Commercializing an MRI Breakthrough
Autor: Jacob Aptekar, Lee Fleming
The challenges and best strategies for the commercialization of university technologies are illustrated in this case which documents an MRI breakthrough that arose from the Charles Marcus laboratory at Harvard. Students discuss the interdependencies
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje